ArticleThe oncologist2016

Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?

Patrizia Mondello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.